Virtual clinical QT exposure-response studies - A translational computational approach
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study used computational cardiac models to predict drug concentration-response relationships for QTc prolongation, finding results comparable to clinical data. This approach aids in drug safety assessment and trial design.
Area Of Science
- Cardiovascular pharmacology
- Computational biology
- Drug safety assessment
Background
- Proarrhythmic risk assessment is shifting towards integrating clinical, non-clinical, and computational evidence.
- Current computational methods predict event incidence, but predicting concentration-response relationships for clinical endpoints like QTc is less explored.
Purpose Of The Study
- To predict the concentration-response relationship of QT interval changes (QTc) using computational models.
- To compare computational predictions with clinical trial data for drug-induced QTc prolongation.
Main Methods
- Developed full-heart computational models simulating human cardiac populations.
- Predicted QT interval changes across a range of drug concentrations.
- Compared computational concentration-QTc relationships with clinical data for moxifloxacin, dofetilide, verapamil, and ondansetron.
Main Results
- Computational models accurately predicted concentration-response slopes for three of four drugs (dofetilide, moxifloxacin, verapamil).
- Predicted critical concentrations for 10 ms QTc prolongation were comparable to clinical trial values (0.5-1x ratio).
- This in silico method demonstrated an ability to approximate human critical concentration values, outperforming other existing methodologies.
Conclusions
- Computational modeling of virtual cardiac populations can generate data comparable to clinical findings.
- This approach can enhance pre-clinical and clinical drug safety evaluations.
- The models offer broad exposure ranges for improved trial design and pre-clinical to clinical translation understanding.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.